Skip to content
NBDC Human Database

No datasets in the cart.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Research list

TSV

Refine

Sort by
Date modified
Per page
20

1–20 / 405

CartResearch IDDataset IDResearch titleAnalysis methodType of dataPlatformsParticipantsAccess criteriaData providerDate publishedDate modified
hum0335
Research on new diagnosis and clinical picture of lymphoproliferative diseases by combining genetic analysis and immunological traits
Sequencing
NGS
(Target Capture, Exome)
  • Illumina NextSeq 500
  • Illumina NovaSeq 6000
Waldenström macroglobulinemia: 10 cases
non IgM-type lymphoplasmacytic lymphoma: 10 cases
T cell lymphoproliferative disease: 1 case
(Japanese)
  • Unrestricted-access
  • Controlled-access (Type I)
  • Akihiko Yokohama
2022-09-142026-10-01
hum0607
Exploratory Biomarker Study Associated with the Investigator-Initiated Clinical Trial of Alectinib for Rare Cancers Harboring ALK Alterations
Sequencing
NGS
(Target capture)
  • Illumina NovaSeq 6000
Rare cancers harboring ALK alterations: 24 cases
(Japanese)
  • Controlled-access (Type I)
  • Shinji Kohsaka
2026-10-012026-10-01
hum0511
Identification of Molecular Markers and Elucidation of Molecular Mechanisms in Aging Using Centenarian Samples
Expression profiling
NGS
(scRNA-seq, scTCR-seq, scCITE-seq, bulk RNA-seq)
  • Illumina NovaSeq X
  • MGI DNBSEQ-G400
28 healthy individuals
(Japanese)
  • Unrestricted-access
  • Controlled-access (Type I)
  • Kosuke Hashimoto
2026-07-302026-09-18
hum0567
The mutiomics analysis on liver tumor with rare liver diseases, including Fontan associated liver diseases
Sequencing; Expression profiling
NGS
(WGS, RNA-seq)
  • Illumina NovaSeq 6000
  • Illumina NovaSeq X Plus
liver cancer caused by rare liver diseases: 13 cases
(Japanese)
  • Controlled-access (Type I)
  • Tatsuya Kanto
2026-09-182026-09-18
hum0600
Elucidation of the Molecular Mechanisms of Advanced Thyroid Cancer through Single-Cell Gene Expression Analysis
Expression profiling
NGS
(scRNA-seq)
  • Illumina HiSeq X
undifferentiated thyroid carcinoma: 3 cases
papillary thyroid carcinoma: 3 cases
(Japanese)
  • Unrestricted-access
  • Controlled-access (Type I)
  • Akiko Iguchi
2026-09-172026-09-17
hum0513
Immune profiling study of COVID-19 vaccine recipients
Expression profiling
NGS
(scRNA-seq, scTCR-seq)
  • MGI DNBSEQ-G400
14 healthy donors who received COVID-19 vaccines
(Japanese)
  • Controlled-access (Type I)
  • Yoshimasa Takahashi
2026-09-082026-09-08
hum0585
Derivation of human post-mitotic cardiomyocytes from tetraploid iPSCs
Expression profiling
NGS
(RNA-seq)
  • MGI DNBSEQ-G400
undifferentiated iPS cells and differentiated cardiomyocytes: 12 samples
(Cell-line)
  • Unrestricted-access
  • Yuichiro Miyaoka
2026-08-282026-08-28
hum0358
Research of genetic abnormalities related to the development and prognosis of adenocarcinoma and squamous cell carcinoma of the cervix and vaginal and vulvar cancer
Sequencing, Expression profiling, Methylation profiling
NGS (Exome, RNA-seq, scRNA-seq, Target bisulfite-seq); Xenium In Situ Gene Expression
  • 10x Genomics Xenium Analyzer
  • Illumina MiSeq
  • Illumina NovaSeq 6000
  • Illumina NovaSeq X Plus
cervical cancer: 19 + 4 + 96 cases
(Japanese)
NIKS18 cell line: 5 samples
(Cell-line)
  • Controlled-access (Type I)
  • Kenbun Sone
2022-12-202026-08-20
hum0343
Development of COVID19 vaccine and evaluation system based on genetics of COVID-19
Sequencing, Genome-wide association, Expression profiling
NGS
(RNA-seq)
SNP-chip
Protein expression
eQTL/sQTL/pQTL
Presence or absence of endogenous herpesvirus 6, anellovirus load
  • Illumina Infinium Asian Screening Array
  • Illumina NovaSeq 6000
  • Olink Explore 3072
COVID-19: 2,393 + 2,148 cases
Healthy controls: 3,289 + 53,269 individuals
(Japanese)
  • Unrestricted-access
  • Controlled-access (Type I)
  • Koichi Fukunaga
2022-05-262026-08-13
hum0405
Research on the identification of cancer stem cells for peidatric and adult malignancies
Expression profiling
Sequencing
Methylation profiling
Histone modification
NGS
(Exome, RNA-seq, small RNA-seq, WGS, Amplicon-seq, scRNA-seq/ADT-seq/TCR-seq, CUT&RUN-seq)
Methylation array
  • Illumina HiSeq X
  • Illumina Infinium MethylationEPIC
  • Illumina NextSeq 550
Pediatric B-cell precursor acute lymphocytic leukemia: 69 cases
Pediatric acute myeloid leukemia: 9 cases
B-cell precursor acute lymphoblastic leukemia: 16 cases
chronic active EBV infection: 65 cases
infectious mononucleosis: 6 cases
4 healthy individuals
(Japanese)
  • Controlled-access (Type I)
  • Junko Takita
2023-12-252026-08-05
hum0444
Research to elucidate pathological conditions of skin diseases caused by genetic alterations by multi-omics analysis
Sequencing
Expression profiling
Methylation profiling
NGS
(WGS, Exome, Long-read WGS, Amplicon-seq, RNA-seq)
SNP array
Methylation array
  • Illumina Infinium Asian Screening Array
  • Illumina Infinium MethylationEPIC
  • Illumina MiSeq
8 porokeratosis patients
3 Nevus spilus-type congenital melanocytic nevus (NS-CMN) patients
(Japanese)
  • Controlled-access (Type I)
  • Akiharu Kubo
2024-04-032026-08-04
hum0197
Elucidation of disease state by multi-layered omics analysis
Metagenome, GWAS, Expression profiling, eQTL, Chromatin structure analysis
Metagenome, SNP-chip, NGS (WGS, RNA-seq, scRNA-seq, snRNA-seq, snATAC-seq), Presence or absence of endogenous herpesvirus 6, anellovirus load, Proteomics
  • Affymetrix Japonica Array
  • Applied Biosystems UK BiLEVE Axiom Array
  • Applied Biosystems UK Biobank Axiom Array
95 + 103 + 227 + 30 + 141 + 136 + 88 + 5 + 524 individuals
BBJ: 180,215 individuals
UK biobank: 377,583 individuals
FinnGen: 136,000 + 224,352 individuals
BACC: 247,173 individuals
PRACTICAL: 140,254 individuals
Autoimmune pulmonary alveolar proteinosis: 198 cases
Control participants: 395
Ulcerative Colitis: 35 cases
Crohn's disease: 39 cases
Healthy controls: 40 individuals
Intracranial germ cell tumors: 133 cases
Control participants: 762
COVID-19: 30 + 43 + 15 cases
Healthy controls: 31 + 44 + 27 individuals
Healthy subjects: 73 individuals
Hunner-type interstitial cystitis: 144 cases
Type 2 diabetes: 27,642 cases (BBJ)
Control participants: 70,242 (BBJ)
Type 2 diabetes: 27,642 cases (UK biobank)
Control participants: 70,242 (UK biobank)
Recurrent pregnancy loss: 1,728 cases
Autoimmune diseases: 2,238 cases
Control participants: 2,919
HPV-associated oropharyngeal cancer: 32 cases
Non-HPV-associated oropharyngeal cancer: 17 cases
Control participants: 2
NMOSD: 240 cases
Control participants: 50,578
Psoriasis: 204 cases
Control participants: 1,231
Japanese males: 161,026 (BBJ, JCTF, TMM, COVC, HERPACC, JPHC)
Japanese male asthma: 3 cases
Japanese male COVID-19: 4 cases
Myasthenia gravis: 1,434 cases
Control participants: 42,913
Moyamoya disease: 401 cases
Control participants: 47,255
multiple sclerosis (MS): 20 cases
MS: 688 cases (Japanese)
Control participants: 205,199
MS: 27,572 cases (European)
Control participants: 1,436,801
MS: 819 cases (African)
Control participants: 155,904
MS: 295 cases (American)
Control participants: 45,569
(Japanese, British, Finnish, African, American)
  • Unrestricted-access
  • Controlled-access (Type I)
  • Yukinori Okada
2019-11-152026-07-31
hum0210
Comprehensive genomic analysis of hematological malignancies
Sequencing, Expression profiling
NGS
(Exome, RNA-seq)
  • Illumina NextSeq 500
  • MGI DNBSEQ-G400
1 patient with concomitant acute myeloid leukemia and mediastinal germ cell tumor
5 patients with adult T-cell leukemia/lymphoma
(Japanese)
  • Controlled-access (Type I)
  • Kazuya Shimoda
2020-04-062026-07-30
hum0574
Construction of a genome analysis database for malignant tumors
Sequencing, Expression profiling
NGS
(Exome, RNA-seq)
  • Illumina NovaSeq 6000
rectal cancer: 2 cases
gastric adenocarcinoma: 4 cases
(Japanese)
  • Controlled-access (Type I)
  • Yoshifumi Shimada
  • Hiroshi Ichikawa
2026-07-242026-07-24
hum0588
Development of Disease Models and Cell Transplantation Therapies through the Optimization of Precise Genome Engineering in Human iPS Cells
Expression profiling
NGS
(RNA-seq)
  • MGI DNBSEQ-G400
undifferentiated iPS cells and differentiated cardiomyocytes: 12 samples
(Cell-line)
  • Controlled-access (Type I)
  • Yuichiro Miyaoka
2026-07-192026-07-19
hum0575
Comprehensive gene expression analysis in renal cell carcinoma
Expression profiling
NGS
(RNA-seq)
  • Illumina HiSeq 1500
  • Illumina HiSeq 2500
  • Illumina NextSeq 550
renal cell carcinoma: 201 cases
(Japanese)
  • Controlled-access (Type I)
  • Renpei Kato
2026-07-162026-07-16
hum0556
Research on the biological characteristics of gene expression profiles and biomarkers for diagnosis and treatment in lung cancer
Histone modification profiling
NGS
(ChIP-seq)
  • Illumina HiSeq 2500
lung cancer: 17 cases
(Japanese)
  • Controlled-access (Type I)
  • Takashi Sato
2026-06-232026-06-23
hum0427
Establishment of cell lines derived from head and neck malignancies / Comprehensive genetic analysis and database construction for head and neck malignancies
Sequencing, Histone modification profiling
NGS
(Exome, ChIP-seq)
  • Illumina NextSeq 500
  • MGI DNBSEQ-G400
external auditory canal squamous cell carcinoma: 1 case
temporal bone squamous cell carcinoma: 5 cases
(Japanese)
  • Controlled-access (Type I)
  • Takashi Nakagawa
2023-11-022026-06-16
hum0543
Research on Large-Scale Genomic Structural Abnormalities and Cancer Genome Evolution in Colorectal Cancer
Sequencing
NGS
(WGS)
  • Illumina NovaSeq 6000
colorectal cancer: 62 cases
(Japanese)
  • Controlled-access (Type I)
  • Shinichi Yachida
2026-06-102026-06-10
hum0214
Integrative understanding of human immune system by functional genomics and development of intervention strategies for the prevention of autoimmune diseases
Expression profiling, eQTL
NGS
(RNA-seq, scRNA-seq)
eQTL
BCR repertoire analysis
TCR repertoire analysis
  • Illumina HiSeq 2500
  • Illumina HiSeq X
  • Illumina NovaSeq 6000
10 Immune-mediated diseases: 544 cases
185 normal controls
(Japanese)
  • Unrestricted-access
  • Controlled-access (Type I)
  • Keishi Fujio
2020-10-092026-06-09

1–20 / 405